WMG Financial Advisors’s Arbutus Biopharma ABUS Stock Holding History

WMG Financial Advisors’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.5K	Hold	12,605	–	–	0.02%	102
2026 Q1	$56.7K	Hold	12,605	–	–	0.02%	98
2025 Q4	$60.6K	Hold	12,605	–	–	0.03%	113
2025 Q3	$57.2K	Hold	12,605	–	–	0.02%	211
2025 Q2	$38.9K	Hold	12,605	–	–	0.01%	189
2025 Q1	$44K	Hold	12,605	–	–	0.02%	169
2024 Q4	$41.2K	Hold	12,605	–	–	0.02%	171
2024 Q3	$48.5K	Hold	12,605	–	–	0.02%	175
2024 Q2	$38.9K	Hold	12,605	–	–	0.02%	155
2024 Q1	$32.5K	Hold	12,605	–	–	0.02%	146
2023 Q4	$31.5K	Hold	12,605	–	–	0.02%	125
2023 Q3	$25.6K	Hold	12,605	–	–	0.02%	99
2023 Q2	$29K	Hold	12,605	–	–	0.02%	123
2023 Q1	$38.2K	Hold	12,605	–	–	0.03%	117
2022 Q4	$29.4K	Hold	12,605	–	–	0.03%	132
2022 Q3	$24K	Hold	12,605	–	–	0.02%	137
2022 Q2	$34K	Buy	+12,605	New	+$32.3K	0.03%	141

Other funds holding ABUS

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

LWA

Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

WMA

Wealth Management Associates Cherry Hill, New Jersey $362M AUM 33.28% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PPWP

Premier Path Wealth Partners Madison, New Jersey $870M AUM 30% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

WMG Financial Advisors's ABUS Position: Q2 2026 in Review

WMG Financial Advisors held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 12,605 shares worth $60.5K. The position accounts for 0.02% of the portfolio, ranked #102.

WMG Financial Advisors first reported a position in ABUS in Q2 2022 and has held it in 17 quarters since. The position peaked at $60.6K in Q4 2025. 25 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

WMG Financial Advisors held 12,605 shares of Arbutus Biopharma worth $60.5K as of Q2 2026.
WMG Financial Advisors left its Arbutus Biopharma share count unchanged in Q2 2026.
Arbutus Biopharma made up 0.02% of WMG Financial Advisors's portfolio in Q2 2026, its #102 holding.
WMG Financial Advisors first reported a position in Arbutus Biopharma in Q2 2022 and has held it in 17 quarters since.
WMG Financial Advisors's Arbutus Biopharma position peaked at $60.6K in Q4 2025.
25 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on WMG Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.